Comparison of randomly amplified polymorphic DNA analysis and pulsed-field gel electrophoresis for typing of Moraxella catarrhalis strains.

PubWeight™: 0.87‹?›

🔗 View Article (PMC 84338)

Published in J Clin Microbiol on February 01, 1999

Authors

H Vu-Thien1, C Dulot, D Moissenet, B Fauroux, A Garbarg-Chenon

Author Affiliations

1: Service de Microbiologie, Hôpital d'Enfants Armand-Trousseau, 75571 Paris Cedex 12, France. hoang.vuthien@trs.ap-hop-paris.fr

Articles cited by this

Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol (1995) 88.05

Fingerprinting genomes using PCR with arbitrary primers. Nucleic Acids Res (1990) 23.96

Branhamella catarrhalis: an organism gaining respect as a pathogen. Clin Microbiol Rev (1990) 2.43

Comparison of arbitrarily primed PCR and macrorestriction (pulsed-field gel electrophoresis) typing of Pseudomonas aeruginosa strains from cystic fibrosis patients. J Clin Microbiol (1995) 1.79

Evaluation of restriction endonuclease analysis as an epidemiologic typing system for Branhamella catarrhalis. J Clin Microbiol (1989) 1.64

Restriction fragment mapping of Branhamella catarrhalis: a new tool for studying the epidemiology of this middle ear pathogen. J Infect Dis (1988) 1.64

Epidemiology of Moraxella catarrhalis in children during the first 2 years of life: relationship to otitis media. J Infect Dis (1994) 1.54

Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum. J Clin Microbiol (1990) 1.50

Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Eur J Clin Microbiol Infect Dis (1996) 1.31

Nosocomial CDC group IV c-2 bacteremia: epidemiological investigation by randomly amplified polymorphic DNA analysis. J Clin Microbiol (1996) 1.11

Dynamics of respiratory tract colonization by Branhamella catarrhalis in bronchiectasis. Am J Respir Crit Care Med (1995) 1.09

Use of molecular methods to characterize Moraxella catarrhalis strains in a suspected outbreak of nosocomial infection. Eur J Clin Microbiol Infect Dis (1992) 0.95

Epidemiological typing of Moraxella catarrhalis by using DNA probes. J Clin Microbiol (1993) 0.91

Restriction fragment length polymorphism (RFLP) of genomic DNA of Moraxella (Branhamella) catarrhalis isolates in a hospital. Microbiol Immunol (1994) 0.86

Articles by these authors

Quantification of human cytomegalovirus DNA by real-time PCR. J Clin Microbiol (2001) 1.82

Predictors of survival in patients receiving domiciliary oxygen therapy or mechanical ventilation. A 10-year analysis of ANTADIR Observatory. Chest (1996) 1.80

Detection of Mycoplasma pneumoniae in clinical samples from pediatric patients by polymerase chain reaction. J Clin Microbiol (1992) 1.70

Patterns of home mechanical ventilation use in Europe: results from the Eurovent survey. Eur Respir J (2005) 1.67

Long term effects of azithromycin in patients with cystic fibrosis: A double blind, placebo controlled trial. Thorax (2006) 1.52

Mycobacterial lung disease in cystic fibrosis: a prospective study. Pediatr Infect Dis J (1997) 1.49

Sniff nasal inspiratory pressure: what is the optimal number of sniffs? Eur Respir J (2006) 1.48

Molecular epidemiology of Streptococcus pneumoniae with decreased susceptibility to penicillin in a Paris children's hospital. J Clin Microbiol (1997) 1.42

Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol (1999) 1.33

Molecular epidemiology of Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans in a cystic fibrosis center. Eur J Clin Microbiol Infect Dis (1996) 1.31

Comparative in vitro activities of caspofungin and micafungin, determined using the method of the European Committee on Antimicrobial Susceptibility Testing, against yeast isolates obtained in France in 2005-2006. Antimicrob Agents Chemother (2007) 1.26

Investigation of an outbreak of wound infections due to Alcaligenes xylosoxidans transmitted by chlorhexidine in a burns unit. Eur J Clin Microbiol Infect Dis (1998) 1.23

Long-term outcome of idiopathic pulmonary hemosiderosis in children. Medicine (Baltimore) (2000) 1.20

Multicentre quality control of polymerase chain reaction for detection of HIV DNA. AIDS (1992) 1.18

Colonization by Alcaligenes xylosoxidans in children with cystic fibrosis: a retrospective clinical study conducted by means of molecular epidemiological investigation. Clin Infect Dis (1997) 1.15

CDC group IV c-2: a new Ralstonia species close to Ralstonia eutropha. J Clin Microbiol (1999) 1.13

Short-term effect of winter air pollution on respiratory health of asthmatic children in Paris. Eur Respir J (1998) 1.13

Nosocomial CDC group IV c-2 bacteremia: epidemiological investigation by randomly amplified polymorphic DNA analysis. J Clin Microbiol (1996) 1.11

Comparative DNA analysis of Bordetella pertussis clinical isolates by pulsed-field gel electrophoresis, randomly amplified polymorphism DNA, and ERIC polymerase chain reaction. FEMS Microbiol Lett (1996) 1.11

Real-time PCR quantification of human cytomegalovirus DNA in amniotic fluid samples from mothers with primary infection. J Clin Microbiol (2002) 1.10

Pulmonary sarcoidosis in children: a follow-up study. Eur Respir J (2001) 1.07

Distribution of human rotavirus G types circulating in Paris, France, during the 1997-1998 epidemic: high prevalence of type G4. J Clin Microbiol (1999) 1.04

Lower respiratory tract illness and RSV prophylaxis in very premature infants. Arch Dis Child (2004) 1.01

Quantification of Epstein-Barr virus load in peripheral blood of human immunodeficiency virus-infected patients using real-time PCR. J Med Virol (2001) 1.01

Comparison of antibody, antigen, and metabolite assays for hospitalized patients with disseminated or peripheral candidiasis. J Clin Microbiol (1990) 1.01

Comparative analysis of VP8* sequences from rotaviruses possessing M37-like VP4 recovered from children with and without diarrhoea. J Gen Virol (1994) 1.00

Idiopathic pulmonary fibrosis in infants. Pediatr Pulmonol (1997) 0.99

Study of genetic reassortment between two human rotaviruses. Virology (1984) 0.97

Quality control of equipment in home mechanical ventilation: a European survey. Eur Respir J (2005) 0.96

Detection of an erythrovirus sequence distinct from B19 in a child with acute anaemia. Lancet (1998) 0.95

A human rotavirus with rearranged genes 7 and 11 encodes a modified NSP3 protein and suggests an additional mechanism for gene rearrangement. J Virol (2001) 0.94

Serological characterization of human reassortant rotaviruses. J Virol (1986) 0.94

Epidemiologic and genomic study of rotavirus strains infecting young children and calves in the same rural environment. Eur J Epidemiol (1986) 0.94

Respiratory medicines for children: current evidence, unlicensed use and research priorities. Eur Respir J (2009) 0.92

Chronic interstitial lung disease in children: response to high-dose intravenous methylprednisolone pulses. Pediatr Pulmonol (1998) 0.89

Limitations of sniff nasal pressure in patients with severe neuromuscular weakness. J Neurol Neurosurg Psychiatry (2003) 0.89

Risk factors for severe respiratory syncytial virus infection in infants. Respir Med (2002) 0.88

Effect of manufacturer-inserted mask leaks on ventilator performance. Eur Respir J (2009) 0.86

Medicines used in respiratory diseases only seen in children. Eur Respir J (2009) 0.85

Genotype analysis and phenotypic manifestations of children with intermediate sweat chloride test results. Chest (2000) 0.85

Epidemiological and clinical study and electrophoretyping survey of rotavirus acute diarrhoea in a children's infectious disease unit in Casablanca, Morocco. Ann Inst Pasteur Virol (1989) 0.84

Miliary tuberculosis with acute respiratory failure and histiocytic hemophagocytosis. Successful treatment with extracorporeal lung support and epipodophyllotoxin VP 16-213. Acta Paediatr (1992) 0.84

Pediatric tonsillectomy: clinical practice guidelines. Eur Ann Otorhinolaryngol Head Neck Dis (2012) 0.83

Simplified enzyme-linked immunosorbent assay for specific antibodies to respiratory syncytial virus. J Clin Microbiol (1986) 0.83

Ralstonia paucula (Formerly CDC group IV c-2): unsuccessful strain differentiation with PCR-based methods, study of the 16S-23S spacer of the rRNA operon, and comparison with other Ralstonia species (R. eutropha, R. pickettii, R. gilardii, and R. solanacearum). J Clin Microbiol (2001) 0.83

Epidemiological study of infantile rotavirus diarrhoea in Tananarive (Madagascar). J Diarrhoeal Dis Res (1993) 0.82

[Mechanical ventilation by nasal mask in children with cystic fibrosis. Initial results of a non-invasive method]. Arch Fr Pediatr (1994) 0.82

Comparison of proportional assist ventilation and pressure support ventilation in chronic respiratory failure due to neuromuscular and chest wall deformity. Thorax (2002) 0.81

[Klebsiella oxytoca septicemia following platelet transfusion]. Pathol Biol (Paris) (1999) 0.81

Measuring inspiratory muscle strength in neuromuscular disease: one test or two? Eur Respir J (2007) 0.81

Expression of insulin-like growth factors and their binding proteins by bronchoalveolar cells from children with and without interstitial lung disease. Eur Respir J (1998) 0.80

[Palivizumab immunoprophylaxis: use in clinical practice, safety and beneficial effects in France]. Arch Pediatr (2009) 0.79

Results of tympanoplasty in children with primary ciliary dyskinesia. Arch Otolaryngol Head Neck Surg (1998) 0.79

Respiratory-related evoked potentials in children with asthma. Neurophysiol Clin (2007) 0.79

Prevalence of asthma or respiratory symptoms among children attending primary schools in Paris. Pediatr Pulmonol (1998) 0.78

[Incidence of rotavirus gastroenteritis among children under 5 years consulting a paediatrician or a general practitioner in France]. Pathol Biol (Paris) (2012) 0.78

[Malnutrition in children with chronic bronchitis]. Arch Pediatr (2008) 0.78

Exhaled nitric oxide in cystic fibrosis: relationships with airway and lung vascular impairments. Eur Respir J (2009) 0.78

BK virus (BKV) detection in urine specimens of immunocompromised patients: comparison between the DNA-DNA hybridization assay, the immunofluorescence test and the dot enzyme immunoassay. Res Virol (1989) 0.77

[Heart or heart-lung transplantation and toxoplasmosis]. Presse Med (1992) 0.77

[Acute diarrhea and rotavirus infection in the child: assessment of data from emergency care and and the microbiology laboratory of the Armand-Trousseau (Paris) Hospital between 1988 and 2001]. Arch Pediatr (2001) 0.77

Daytime predictors of sleep-disordered breathing in neuromuscular patients to better schedule polysomnography. Eur Respir J (2011) 0.77

Effect of laser irradiation on latency of herpes simplex virus in a mouse model. Pathol Biol (Paris) (1997) 0.76

Raman spectroscopic analysis of the clonal and horizontal spread of CTX-M-15-producing Klebsiella pneumoniae in a neonatal intensive care unit. Eur J Clin Microbiol Infect Dis (2012) 0.76

[Description and investigation of an outbreak of extended-spectrum beta-lactamase producing Escherichia coli strain in a neonatal unit]. Arch Pediatr (2010) 0.76

Limits of sequencing and phylogenetic analysis to assess B19V transmission by single-donor blood component. Vox Sang (2010) 0.76

Conservative use of chest-tube insertion in children with pleural effusion. Pediatr Surg Int (2006) 0.75

[Cytomegalovirus, pregnancy and occupational risk]. Arch Pediatr (1998) 0.75

Non-invasive mechanical ventilation: when to start for what benefit? Thorax (2005) 0.75

Parvovirus B19 infection, hepatitis C virus infection, and mixed cryoglobulinaemia. Ann Rheum Dis (1998) 0.75

Lack of association between B19 or V9 erythrovirus infection and ANCA-positive vasculitides: a case-control study. Rheumatology (Oxford) (2003) 0.75

Requisite for stringent control of oxygen therapy in the neonatal period. Eur Respir J (2007) 0.75

[Disseminated fusarium infection in two neutropenic children]. Arch Pediatr (2005) 0.75

[Management of patients with cystic fibrosis: role of corticosteroid therapy]. Rev Mal Respir (2003) 0.75

The effect of trypsin on the growth in vitro of adenoviruses present in faeces. Ann Inst Pasteur Virol (1989) 0.75

Pseudomonas (Burkholderia) cepacia in children with cystic fibrosis: epidemiological investigation by analysis or restriction fragment length polymorphism. Pathol Biol (Paris) (1996) 0.75

Paediatric HERMES: update of the European Training Syllabus for Paediatric Respiratory Medicine. Eur Respir J (2009) 0.75

[Bronchiolitis caused by respiratory syncytial virus in very young infants and transmitted maternal antibodies]. Arch Fr Pediatr (1988) 0.75

Nutrition and severe chronic respiratory diseases: the pediatric experience. Pediatr Pulmonol (2001) 0.75

[Bacteriological control of water in dental equipment. Study of 9 health units]. Chir Dent Fr (1987) 0.75

[Rotavirus vaccines]. Arch Pediatr (1999) 0.75

[From structural and antigenic features of the rotavirus to the development of the vaccines]. Arch Pediatr (2007) 0.75

[Sleep-disordered breathing in children]. Arch Pediatr (2008) 0.75

[Best clinical practices for aerosol nebulization therapy approved at the National Meeting on Nebulization, Paris 4-5 April 1997]. Ann Otolaryngol Chir Cervicofac (2000) 0.75

[Three challenges for the journal]. Rev Mal Respir (2001) 0.75

[Pneumocystis jiroveci pneumonia during prolonged corticosteroid therapy in an immunocompetent infant]. Rev Pneumol Clin (2008) 0.75

[Rotavirus infection in the newborn infant: epidemiologic study]. Ann Pediatr (Paris) (1987) 0.75

[Viruses of pediatric gastroenteritis]. Ann Pediatr (Paris) (1987) 0.75

[Noninvasive ventilation: interest and practical aspects in pediatric practice]. Arch Pediatr (2009) 0.75

[Use of deoxyribonucleic acid probes in infectious pathology]. Presse Med (1988) 0.75

[Sternal swelling in a nine-year-old child]. Med Mal Infect (2008) 0.75

[Diseases of the pulmonary lymphatic system in children]. Rev Pneumol Clin (2003) 0.75

DNA hybridization for detection of human cytomegalovirus in bronchoalveolar lavage and pharynx biopsy. Ann Inst Pasteur Virol (1989) 0.75

[Virological tests: ever more or even better]. Presse Med (1987) 0.75

[Molecular epidemiology of pneumococci with decreased susceptibility to penicillin isolated in a Parisian pediatric hospital]. Pathol Biol (Paris) (1996) 0.75